ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,887Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 551

$1.24M Total Retail Price of All Prescriptions

Rank: 5 out of 551

1,250 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,250 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 29,100 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
GABAPENTIN 2,032 1,594 10 1 3
SIMVASTATIN 1,892 1,511 2 1
OMEPRAZOLE 1,269 1,012 3 7
RANITIDINE HCL 1,078 825 4 8
METFORMIN HCL 990 720 5 2
AMLODIPINE BESYLATE 963 791 6 4
LOSARTAN POTASSIUM 912 735 7 6
GLIPIZIDE 863 637 10 8 20
SYNTHROID 769 640 9 11
FAMOTIDINE 705 519 10 31
LEVOTHYROXINE SODIUM 704 566 11 9
ENALAPRIL MALEATE 702 540 12 5
LOSARTAN-HYDROCHLOROTHIAZIDE 658 549 13 10
HYDROCHLOROTHIAZIDE 646 510 14 15
LISINOPRIL 645 504 15 14
TRAMADOL HCL-ACETAMINOPHEN 571 367 16 18
DICLOFENAC POTASSIUM 524 390 10 17 45
METOPROLOL TARTRATE 523 414 18 17
FUROSEMIDE 513 429 19 13
GLYBURIDE-METFORMIN HCL 472 392 R 20 48
HUMULIN 70-30 449 361 10 21 35
AZITHROMYCIN 445 314 22 55
ATENOLOL 441 352 23 12
ATORVASTATIN CALCIUM 363 288 24 29
CLOPIDOGREL 334 267 25 30
ISOSORBIDE MONONITRATE ER 333 306 26 21
GEMFIBROZIL 323 232 27 61
PLAVIX 320 268 28 33
WARFARIN SODIUM 315 230 29 46
FLUTICASONE PROPIONATE 303 196 30 66
CILOSTAZOL 293 248 31 64
MECLIZINE HCL 292 251 32 56
SERTRALINE HCL 274 232 33 43
PANTOPRAZOLE SODIUM 265 176 34 36
INSULIN SYRINGE 255 179 35 41
METOPROLOL SUCCINATE 251 217 36 23
FEXOFENADINE HCL 244 173 10 37 143
MEGESTROL ACETATE 244 239 R 37 115
DIGOXIN 244 208 37 44
ZOLPIDEM TARTRATE 240 191 40 27
ALENDRONATE SODIUM 218 184 41 19
CARVEDILOL 210 160 42 22
SINGULAIR 209 145 43 58
CEFADROXIL 200 158 44 153
MUPIROCIN 198 134 45 185
GLIMEPIRIDE 192 142 46 16
CLOTRIMAZOLE-BETAMETHASONE 190 131 47 49
PREDNISONE 189 122 48 65
NABUMETONE 183 102 49 37
AMLODIPINE BESYLATE-BENAZEPRIL 183 162 49 42
RAMIPRIL 182 145 51 53
ASPIRIN EC 181 156 52 26
AVELOX 179 132 10 53 148
TAMSULOSIN HCL 173 149 54 38
PROAIR HFA 171 91 55 92
DOXAZOSIN MESYLATE 171 148 55 25
IRBESARTAN 166 128 57 51
VERAPAMIL ER 165 137 58 39
TRAMADOL HCL 163 112 59 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 131 60 59
LANSOPRAZOLE 158 131 61 72
NIFEDIPINE ER 156 118 62 75
CIPROFLOXACIN HCL 154 120 63 54
CRESTOR 150 121 64 62
DEXAMETHASONE 144 105 65 111
LANTUS 144 139 65 28
CLOTRIMAZOLE 142 96 67 160
BETAMETHASONE DIPROPIONATE 140 110 68 127
CAPTOPRIL 136 113 69 63
HUMULIN N 128 77 70 47
JANUVIA 128 99 70 87
BISOPROLOL-HYDROCHLOROTHIAZIDE 128 80 70 112
DONEPEZIL HCL 126 125 73 50
AVAPRO 122 98 74 83
AMITRIPTYLINE HCL 114 105 R 75 96
ADVAIR DISKUS 113 78 76 97
DIOVAN HCT 112 85 77 71
PENTOXIFYLLINE 112 71 77 73
ZETIA 111 71 79 69
LYRICA 106 70 80 86
SURE COMFORT 101 53 81 74
EVISTA 99 89 82 52
DIOVAN 98 81 83 57
METOCLOPRAMIDE HCL 94 58 84 107
COUMADIN 90 67 85 88
LOPERAMIDE 89 46 86 211
VERAPAMIL HCL 89 63 86 216
SULINDAC 88 73 88 78
ETODOLAC 88 69 88 95
GLYBURIDE MICRONIZED 88 78 R 88 91
MOMETASONE FUROATE 88 68 88 173
LEVETIRACETAM 87 66 92 182
OXYCODONE-ACETAMINOPHEN 85 37 S2 93 102
SUCRALFATE 84 62 94 120
DESONIDE 82 77 95 233
PAROXETINE HCL 81 59 96 77
PHENYTOIN SODIUM EXTENDED 77 57 97 163
DILANTIN 77 52 97 199
CARAFATE 76 39 99 130
DICLOFENAC SODIUM 76 67 99 99
NAPROXEN 76 49 99 80
GLIPIZIDE ER 76 64 99 85
DILTIAZEM HCL 76 65 99 106
CETIRIZINE HCL 75 60 104 154
HUMALOG MIX 75-25 75 61 104 110
CLONIDINE HCL 74 45 106 60
ALBUTEROL SULFATE 74 52 106 170
JANUMET 74 69 106 109
FOSINOPRIL SODIUM 72 72 109 89
AMOX TR-POTASSIUM CLAVULANATE 71 49 110 113
TRICOR 71 63 110 126
DIPHENHYDRAMINE HCL 70 55 R 112 268
FENOFIBRATE 69 54 113 34
INDOMETHACIN 68 44 R 114 200
BENAZEPRIL HCL 68 56 114 183
FLUCONAZOLE 68 47 114 169
GLIPIZIDE XL 66 58 117 81
TRILIPIX 64 55 118 158
ORPHENADRINE CITRATE 63 23 R 119 147
LEVOFLOXACIN 63 42 119 117
COLCRYS 63 12 119 227
NEOMYCIN-POLYMYXIN-HYDROCORT 54 43 122 265
MONTELUKAST SODIUM 53 29 123 156
KETOCONAZOLE 52 41 124 134
NAMENDA 52 51 124 94
HUMALOG 52 26 124 101
BUMETANIDE 51 39 127 108
LATANOPROST 51 47 127 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.